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The extracellular matrix (ECM) plays an important role in numerous processes including cellular prolif-
eration, differentiation, migration, maturation, adhesion guidance and axonal growth. To date, there has
been no detailed analysis of the ECM distribution during retinal ontogenesis in humans and the func-
tional importance of many ECM components is poorly understood. In this study, the expression of key
ECM components in adult mouse and monkey retina, developing and adult human retina and retinal
organoids derived from human pluripotent stem cells was studied. Our data indicate that basement
membrane ECMs (Fibronectin and Collagen IV) were expressed in Bruch’s membrane and the inner lim-
iting membrane of the developing human retina, whilst the hyalectins (Versican and Brevican), cluster of
differentiation 44 (CD44), photoreceptor-specific ECMs Interphotoreceptor Matrix Proteoglycan 1
(IMPG1) and Interphotoreceptor Matrix Proteoglycan 2 (IMPG2) were detected in the developing inter-
photoreceptor matrix (IPM). The expression of IMPG1, Versican and Brevican in the developing IPM
was conserved between human developing retina and human pluripotent stem cell-derived retinal orga-
noids. Blocking the action of CD44 and IMPG1 in pluripotent stem cell derived retinal organoids affected
the development of photoreceptors, their inner/outer segments and connecting cilia and disrupted IPM
formation, with IMPG1 having an earlier and more significant impact. Together, our data suggest an
important role for IMPG1 and CD44 in the development of photoreceptors and IPM formation during
human retinogenesis.
Statement of Significance
The expression and the role of many extracellular matrix (ECM) components during human retinal devel-
opment is not fully understood. In this study, expression of key ECM components (Collagen IV,
Fibronectin, Brevican, Versican, IMPG1 and IMPG2) was investigated during human retinal ontogenesis.um; FN1,
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208 M. Felemban et al. / Acta Biomaterialia 74 (2018) 207–221Collagen IV and Fibronectin were expressed in Bruch’s membrane; whereas Brevican, Versican, IMPG1 &
IMPG2 in the developing interphotoreceptor matrix (IPM). Retinal organoids were successfully generated
from pluripotent stem cells. The expression of ECM components was examined in the retinal organoids
and found to recapitulate human retinal development in vivo. Using functional blocking experiments, we
were able to highlight an important role for IMPG1 and CD44 in the development of photoreceptors and
IPM formation.
 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
The final impact of many forms of blinding diseases is the loss of
photoreceptors, a specialised type of photosensitive neurons that
are capable of photo-transduction, and/or the underlying retinal
pigment epithelium (RPE) [1]. No treatments currently exist to
restore lost photoreceptor cells and the accompanying vision loss
which occurs in many retinal diseases. Thus, there is a pressing
need to generate a source of functional photoreceptors and RPE,
the underlying tissue which is essential for photoreceptor function
and viability, for disease modelling and transplantation. The feasi-
bility of this approach is supported by the fact that replacement
photoreceptors transplanted into the fovea need only a single
synaptic connection with the inner retina [2]. The retina is a prime
system within which to test the development of cell transplanta-
tion therapies due to the relative accessibility of the eye that per-
mits local delivery of cells with minimum risk of systemic
consequences. Human embryonic stem cells (hESCs) and induced
pluripotent stem cells (hiPSCs) are an attractive solution for cell
replacement therapies as they offer the prospect of generating
unlimited quantities of desired cell types for transplantation [3].
In the last few years several groups, including ours, have demon-
strated the generation of laminated retinal organoids from human
pluripotent stem cells containing multiple retinal cells types which
interact with each other, form synaptic connections, respond to
electrophysiological stimuli [1,4–9] and engraft within the degen-
erate retinae [10]. Such organoid cultures provide an extremely
useful tool for large scale pharmacology and toxicology testing,
understanding human retinal development and dissecting the role
of individual genes during this process. As such, it is important to
ensure that in vitro pluripotent stem cell models are similar coun-
terparts to the retinal tissue in vivo.
The extracellular matrix (ECM) is the non-cellular component of
all tissues and organs. It consists of proteins, water, polysaccha-
rides and glycosaminoglycans (GAGs), and varies in composition
from one tissue to the next [11]. The ECM acts as a structural sup-
port that facilities cell adhesion via integrins and other adhesion
molecules which mediate signalling pathways essential for cell
proliferation, migration and differentiation [12–14]. It also pro-
vides biochemical and biomechanical cues that are essential for tis-
sue morphogenesis [11].
In the retina, the ECM is divided into two distinct entities,
namely: 1) the interphotoreceptor matrix (IPM) which surrounds
the inner and outer segments of the photoreceptors and plays a
significant role in retinal adhesion [15], retinoid transport [15],
photoreceptor differentiation [16] and intercellular communica-
tion [17] and 2) the retinal ECM that surround other cells of the
retina [18]. Various studies of rat, mouse, chicken and human
retina [19–24] have shown that the localisation of ECM molecules
varies between developmental stages [22] and species [21]. During
retinal development, different ECM molecules including Fibronec-
tin, Collagen IV and Laminins are required for optic cup morpho-
genesis [20]. For example, in chick embryos, removing the
surface ectoderm and disrupting the surrounding ECM withcollagenase results in the curvature of the optic vesicle at early
stages of invagination and inhibition of subsequent invagination
and optic cup formation [25]. Blocking the interaction of rat retinal
progenitor cells with laminin b2 in vitro, reduces the fraction of
cells that express rhodopsin, suggesting that this laminin could
be important for rod photoreceptor differentiation [26]. Knock-
down of laminin b2 also results in elongation of photoreceptor
outer segments (OS), abnormal electroretinogram, and atypical
synapse formation of rod photoreceptors and apoptosis in mice
[27], whilst double knockout of laminin b2 and laminin c3 in mice
leads to the disruption of the inner limiting membrane (ILM) and
retinal dysplasia [28].
Collagen IV, Laminin and Fibronectin are the main ECM compo-
nents of the basement membranes including Bruch’s membrane
(BrM) and the ILM [19,20]. Basement membranes are essential
for structural support, cellular adhesion, differentiation, prolifera-
tion, migration and intercellular communication [29]. A recent
study has shown a direct link between increased expression of
Fibronectin at the mRNA level and the thickening of BrM in animal
models of diabetic retinopathy [30]. Inhibition of Fibronectin
assembly in vitro prevents Collagen IV accumulation and thus
could be a contributor to the development of fibrotic disease in
age-related macular degeneration [31]. Mutations in Collagen IV
genes (COL4A3, COL4A4, or COL4A5) were also reported in Alport
syndrome patients and mice with ocular anterior segment dysgen-
esis [32].
Brevican and Versican are members of the hyalectin family
which has been shown to play an important role in maintaining
adhesion between the RPE and neurosensory retina as well as
BrM [22]. Brevican and Versican bind to Hyaluronic Acid from their
N-terminal region and are involved in the development of the cen-
tral nervous system [23]. Hyaluronic Acid is expressed in the IPM
and creates a scaffold that fills the matrix as well as binding to sev-
eral proteins of the IPM such as Versican, IMPG1 and IMPG2 [3,24].
IMPG1 & IMPG2 are proteoglycans found in the IPM and shown to
be involved in the development and maintenance of the photore-
ceptors in mice and human [33–35]. IMPG1 mutations were
reported in Vitelliform macular dystrophies leading to impaired
metabolism of the IPM and the accumulation of Vitelliform depos-
its in the sub-retinal space [36]. A splice mutation in the Versican
gene (VCAN) was reported in Wagner syndrome patients with reti-
nal detachment [37], whilst mutations in IMPG2 cause progressive
degeneration of the photoreceptors, leading to autosomal domi-
nant retinitis pigmentosa [36,38].
Most studies of the ECM expression accompanying retinal his-
togenesis have been performed in animal models due to the ethical
issues associated with and scarcity of human embryonic and foetal
retina. Pluripotent stem cells encompassing hESC and hiPSC pro-
vide a valuable platform for modelling retinal disorders, under-
standing human foetal ontogenesis and providing an unlimited
cell source for cell based replacement therapies [1,3,39]. The pro-
cess of cell lineage differentiation can be directed and functionally
enhanced by supplementation with various ECM components. For
example, hESC derived neural progenitors express RPE markers
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tured on laminin coated surfaces respectively [40]. Matrigel and
Laminin-111 also support the highest level of pigmentation fre-
quency in iPSC-derived RPE cells [41].
Given that human retina develops largely in utero, it is impera-
tive to understand the expression of ECM components during reti-
nal ontogenesis, in order to use this knowledge to improve the
differentiation of pluripotent stem cells to retinal organoids and
understand the role of various ECM components in retinal develop-
ment and disease [21,22]. To date, there has been no detailed anal-
ysis of ECM component distribution during human ophthalmic
development and so the functional importance of ECM in retinal
ontogenesis is poorly understood [40]. In this manuscript, a
detailed expression study of Collagen IV, Fibronectin, Versican, Bre-
vican, IMPG1, CD44 and IMPG2 was undertaken in adult mouse,
monkey and human retina, developing human embryonic and foe-
tal retina, and in retinal organoids developed from hESCs and
hiPSCs. The role of CD44 and IMPG1 was further investigated by
functional blocking experiments in developing retinal organoids
in vitro.2. Materials & methods
2.1. Preparation of retinal sections from mouse and macaque monkey
Eyes were removed post-mortem from macaque monkeys
which had undergone experiments under terminal anaesthesia as
part of an unrelated study into the neural control of movement.
That study was carried out under the approval of the Newcastle
University Animal Welfare and Ethical Review Board, and under
appropriate licences from the UK Home Office. Mouse eyes were
obtained from wild type mice (C57BL/6 background, 7 months
old) from the Functional Genetic Unit, Institute of Genetic Medi-
cine, Newcastle University. Mice were sacrificed humanely via cer-
vical dislocation. For wax sections, mouse and monkey eyes were
dissected from the orbit and immediately transferred to phosphate
buffered saline (PBS, Sigma, UK). The anterior portion was removed
using micro-scissors and forceps, and fixed in 4% (v/v)
paraformaldehyde (PFA) at 4 C overnight. Eye fixation was fol-
lowed by dehydration steps through increasing concentrations of
ethanol (50%, 70%, 95% and 100%) before clearing in histoclear
and embedding in paraffin wax [42] (pastillated Gurr wax, VWR,
UK). 6 lm thick sections were cut on a microtome and collected
onto slides (Superfrost Plus, Thermo Scientific, UK) then stored at
room temperature (RT) protected from light and dust.2.2. Preparation of retinal sections from adult human eyes
Adult human eyes were obtained from Manchester Eye Bank,
Manchester Royal Eye Hospital. Three eyes were collected from
three adult donors 48 h after death (a female aged 84 years and
two males aged 67 and 88 years). The tissue was stored in organ
culture medium at 34 C for 7 days before screening them for bac-
teria and fungi using blood agar plates and liquid microbiological
media [43]. Organ culture medium was composed of Eagle’s Mini-
mum Essential Medium (MEM) containing 26 mM sodium bicar-
bonate, 20 mM HEPES buffer, 2% Fetal Bovine Serum (FBS;
Australian origin, Life Technology Ltd, UK), 2 mM L-glutamine,
penicillin (100 U/mL), streptomycin (0.1 mg/mL), and ampho-
tericin B (0.25 mg/mL) [43]. All consumables used for storage were
from Sigma-Aldrich Company Ltd (UK) except for FBS. Adult
human eyes were fixed in 4% PFA, cryoprotected in PBS containing
30% sucrose overnight and embedded in OCT (Cell Path Ltd., New-
town, UK) and 20 lm thick sections were collected.2.3. Human developmental tissue
Human embryonic and foetal specimens aged between 6 and
19 weeks of post-conception (PCW) were obtained from the
MRC/Wellcome-Trust funded Human Developmental Biology
Resource at Newcastle University (HDBR, http://www.hdbr.org),
with appropriate maternal written consent and approval from
the Newcastle and North Tyneside NHS Health Authority Joint
Ethics Committee. HDBR is regulated by the UK Human Tissue
Authority (HTA; www.hta.gov.uk) and operates in accordance with
the relevant HTA Codes of Practice. Ready-prepared 10 mm paraffin
wax sections were collected from the HDBR and stored at 4 C in
slide boxes prior to immunostaining.
2.4. Immunohistochemistry for ECM proteins
Expression of ECM proteins was determined using immunohis-
tochemistry (IHC). Tissue sections were dewaxed in histoclear,
cleared in 100% ethanol, then rehydrated through several incuba-
tions in decreasing concentrations of ethanol (90%, 70% and 50%)
followed by two washing steps in PBS [42]. For antigen retrieval,
the tissue was placed in citrate buffer (pH 6.3) and microwaved
at high power for 10 min. Non-specific epitope binding was
blocked by incubation at RT for 45 min with PBS containing 10%
(v/v) FBS.
Primary antibodies were diluted in PBS containing 2% FBS
(Table 1), applied on tissue sections and incubated overnight at
4 C. After washing, appropriate fluorescently-labelled secondary
antibodies (Table 2) diluted in PBS containing 2% (v/v) FBS were
added to each tissue section and incubated at room temperature
for 1.5 h in a dark humidified chamber. To quench the auto-
fluorescence in samples, tissue sections were incubated in 0.3%
(w/v) Sudan Black (prepared in 70% ethanol) for 15 min at room
temperature [44], washed in PBS, then mounted with Vectashield
medium containing Hoechst as a nuclear counter-stain. Tissue sec-
tions were air-dried, washed several times with PBS and blocked
with PBS containing 10% normal goat serum or donkey serum
and 0.3% Triton-X-100 for 1 h at room temperature. Primary anti-
bodies (Table 1) were diluted in antibody diluent solution (ADS;
PBS containing 1% bovine serum albumin (BSA) and 0.3% Triton–
X-100) and applied overnight. After several washing steps in
ADS, secondary antibodies (Table 2) were diluted in ADS and sec-
tions were incubated for 2 h at RT. After washing with PBS, sections
were mounted with VectaShield (Vector Laboratories, Burlingame,
CA) containing Hoechst (Life Technologies).
To assess the specificity of primary antibody binding, these
were omitted and replaced with isotype controls (Table 1). For
all antibodies, no non-specific binding was observed (Fig. S1). To
assess the specificity of secondary antibody staining, primary anti-
bodies were omitted. Again no non-specific binding was observed
(Fig. S2).
2.5. Human pluripotent stem cells differentiation to retinal organoids
Retinal organoids were generated from two different cell lines:
hiPSCs derived from adult fibroblasts (SB-Ad3) [45] and human
embryonic stem cells (H9, Wicell Inc.). Stem Cells were expanded
in mTeSRTM1 (StemCell Technologies, 05850) at 37 C and 5% CO2
on 6 well plates pre-coated with Low Growth Factor Matrigel
(Corning, 354230). The retinal organoids were generated following
the method described in Mellough et al., 2015 [7] with the addition
of ROCK inhibitor (Y-27632 dihydrochloride) (10 mM) for the first
48 h of differentiation. Further modifications include the addition
of 10% Fetal Calf Serum, T3 (40 ng/ml), Taurine (0.1 mM) & Retinoic
Acid (0.5 mM) from day 18 of differentiation. Retinal organoids
were collected on day 35, 90 and 150 for IHC. After collection,
Table 1
List of primary antibodies and isotype controls used for the immunohistological analysis.
Antibody Tissue Cat. No. Host Source Dilution
AP2a Amacrine cells sc-12726 Mouse Santa Cruz 1:200
ARL13B Connecting cilium ab83879 Rabbit Abcam 1:500
BCAN ECM ab111719 Rabbit Abcam 1:50
Caspase-3 Apoptotic cells 9661S Rabbit Cell Signaling Technology 1:200
CD44 ECM ab119348 Rat Abcam 1:100
Collagen IV ECM ab6586 Rabbit Abcam 1:100
Cone Arrestin Cone photoreceptors NBP2-41249 Rabbit Novus Biologicals 1:100
CRALBP RPE & Muller cells GTX15051 Mouse Genetex 1:100
CRX post-mitotic photoreceptors H00001406-M02 Mouse Abnova 1:200
CRYAA Lens – Mouse Provided by Prof.
Roy Quinlan
Durham University, UK
1:50
Donkey anti-goat IgG IMPG2-Isotype Control 705-005-147-JIR Donkey Jackson ImmunoResearch 1:1300
Donkey anti-rabbit IgG BCAN-Isotype Control 711-005-152-JIR Donkey Jackson ImmunoResearch 1:65
Collagen IV-Isotype Control 1:130
IMPG1-Isotype Control 1:260
FN1 ECM sc-8422 Mouse Santa Cruz Biotechnology 1:20
Goat anti-mouse IgG1 FN1-Isotype Control NB7508 Goat Novus Biologicals 1:100
Goat anti-mouse IgM VCAN-Isotype Control NB7494 Goat Novus Biologicals 1:100
Goat anti-rat IgG2b CD44-Isotype Control NB7127 Goat Novus Biologicals 1:100
HuC/D amacrine and retinal ganglion cells A21271 Mouse Invitrogen 1:200
IMPG1 ECM Ab113493 Rabbit Abcam 1:100
IMPG2 ECM sc-103232 Goat Santa Cruz Biotechnology 1:200
Ki-67 Proliferating cells ab15580 Rabbit Abcam 1:200
Opsin red/green
(OPN1LW/MW)
L/M cone photoreceptors AB5405 Rabbit Millipore 1:200
PAX6 retinal progenitors,
amacrine and ganglion cells
ab78545 Mouse Abcam 1:200
PROX1 horizontal, bipolar and amacrine cells AB5475 Rabbit Millipore 1:1000
RBP3 IPM 14352-1-AP Rabbit ProteinTech 1:100
Recoverin photoreceptors and midget OFF bipolar cells AB5585 Rabbit Millipore 1:1000
RetP1
(Rhodopsin)
Rod photoreceptors O4886 Mouse Sigma 1:200
Syntaxin presynaptic plasma membrane S0664 Mouse Sigma 1:200
VCAN ECM MABT161 Mouse Millipore 1:100
vGlut1 synaptic terminals of photoreceptors and bipolar cells AB5905 Guinea Pig Millipore 1:1000
VSX2 retinal progenitor cells & bipolar cells HPA003436-100UL Rabbit Sigma 1:50
WGA* inner/outer segments of rods/cones W11261 N/A Invitrogen 1:1000
* WGA - conjugated antibody to Alexa Fluor 488.
Table 2
List of fluorescently labelled secondary antibodies used for the immunohistological analysis.
Antibody Cat. No. Host Source Dilution
anti-mouse Alexa 488 A11001 Goat Life Technologies 1:800
anti-rabbit Cy3 111-165-003 Goat Jackson ImmunoResearch
anti-goat Cy3 305-165-003 Rabbit Jackson ImmunoResearch
anti-donkey
DyLight 488
SA5-10062 Rabbit Life Technologies
Anti-Guinea pig Cy3 AP108C Goat Millipore
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three washes in PBS, then overnight cryoprotection in 30% sucrose
in PBS before embedding in OCT medium (Cellpath, UK) and freez-
ing at 20 C. 10 mm cryostat sections were collected onto Super-
frost Plus slides using a Leica Cm1860 cryostat and stored at
20 C in slide boxes prior to immunostaining.2.6. Blocking IMPG1 and CD44 cellular receptors in retinal organoids
The role of IMPG1 and CD44 in photoreceptor differentiation
was investigated using blocking antibodies to IMPG1 (Abcam,
ab113493) and CD44 (Abcam, ab119348). The antibodies were
added (10 lg/ml) to retinal organoid culture media at day 90 and
150 of the differentiation process. After 14 days in culture, the
effects of IMPG1 and CD44 receptor inhibition was assessed
and compared to a control group which was incubated with(10 lg/ml) non-specific control IgG blocking antibody (Jackson
ImmunoResearch, 209-005-088) by IHC and qRT-PCR.2.7. Image capture and analysis
Images were captured using an Axio Imager upright microscope
with Apotome (Zeiss, Germany) structured illumination fluores-
cence using 20 objective and 40 oil objective operated with
AxioVision software. A range of fluorescent filters were used to
cover several dyes including Hoechst, Cy3 and Alexa 488. Tissue
sections of two biological replicates of developing and adult retina
and three biological replicates of pluripotent stem cell derived reti-
nal organoids were analysed. Cell image quantitation was per-
formed using the MATLAB software. The data was presented as
image segmentation through Hysteresis thresholding technique
to segment the cells and filter out any noise background from
M. Felemban et al. / Acta Biomaterialia 74 (2018) 207–221 211the images [46]. Using measuring property of MATLAB (region-
props), all the pixels of each image were represented as single
region in order to extract the information about each cell including
the size, average intensity value and length. After obtaining the
final segmentation information, the total size and the percentage
of the positive cells were calculated and exported as excel file for
further analysis.
2.8. qRT-PCR
15–20 retinal organoids were homogenised using a Dounce Tis-
sue Grinder (Sigma Aldrich, UK) and RNA was extracted using the
Promega tissue extraction kit (Promega, USA) as per the manufac-
tures instructions. 1 lg of RNA was reverse transcribed using ran-
dom primers (Promega, USA). qRT-PCR was performed using a
Quant Studio 7 Flex system (Applied Biosystems, USA) with SYBR
Green reaction mixture (Promega, USA). Each primer (Table 3)
was used at a concentration of 1 lM, and at a ratio of 50:50 for for-
ward and reverse. The reaction parameters were as follows: 95 C
for 15 min to denature the cDNA and primers, 40 cycles of 94 C
for 15 s followed by primer specific annealing temperature for
30 s (60 C), succeeded by a melt curve. A comparative Ct (cycle
threshold) method was used to calculate the levels of relative
expression, whereby the Ct was normalised to the endogenous
control (GAPDH). This calculation gives the DCt value, which was
then normalised to a reference sample (i.e. a positive control), giv-
ing the DDCt. The fold change was calculated using the following
formula: 2-DDCt.
2.9. Measurements of neuroepithelium thickness
Bright filed images of retinal organoids were taken using a
bright field microscope AxioVert (Zeiss, Germany). The morphol-
ogy of day 90 and 150 retinal organoids was assessed at day 7,
10 and 14 after incubation with the anti-IMPG1, anti-CD44 and
control blocking antibodies. Measurements of neuroepithelium
thickness in retinal organoids were performed using ImageJ. A total
of three biological replicates (n = 3) were assessed from each
hESCs- and hiPSCs- derived retinal organoids. Each biological repli-
cate of day 90 and 150 retinal organoids included 25 measure-
ments from each group (control, anti-IMPG1 and anti-CD44) and
the neuroepithelium thickness were measured at three time point
(day 7, 10 and 14) after the addition of blocking antibodies.
2.10. Statistical analyses
All statistical analyses were performed using Prism software
(GraphPad, USA). The standard errors of all means (SEM) were
calculated. Statistical significance of differences was tested with
two-tailed Student’s t-test for paired samples for neuroepithelium
thickness, qRT-PCR data and cell image quantitation and
Mann-Whitney U test (Wilcoxon Rank-Sum test) for RNA-
sequencing data. *p-value < 0.05, **p-value < 0.01, ***p-value < 0.001,
****p-value < 0.0001.Table 3
List of primers used for qRT-PCR study.
Gene Forward Primer
(Sequence (50–>30)
GAPDH TGCACCACCAACTGCTTAGC
OPSINLW GCCTACTTTGCCAAAAGTGC
RBP3 AGATCATGCACACGGATGCC
RCVRN TTCAAGGAGTACGTCATCGCC
RHO TTTGGAGGGCTTCTTTGCCA3. Results
3.1. Fibronectin, Collagen IV, Versican, Brevican, IMPG1 & IMPG2
expression in adult retina
In order to understand retinal ECM composition during devel-
opment, IHC was performed on adult mouse, monkey and human
retinae. Fibronectin and Collagen IV were expressed in BrM in adult
mouse, monkey and human retinae (Fig. S3). Fibronectin was also
expressed in the ILM in all three species (Fig. S3). Fibronectin and
Collagen IV expression around blood vessels was also observed in
monkey (Fibronectin) and human adult retina (Collagen IV). Colla-
gen IV expression was also observed in the OPL, INL, IPL, GCL and
ILM of adult human retina (Fig. S3).
Versican expression was conserved across adult mouse, monkey
and human retinae (Fig. S4) with strong expression around the OS
of the photoreceptors, and partially co-localised with the IPM mar-
ker, Retinol Binding Protein 3 (RBP3) (Fig. S4). Versican was faintly
expressed in other retinal layers of monkey and adult human
retina. The expression of Brevican varied between all three species;
showing expression in the RPE, around outer and inner segments of
photoreceptors, OPL, INL and GCL in adult mouse retinae, all retinal
layers except OS in adult monkey retinae, and the INL, IPL and gan-
glion cell layers in adult human retinae (Fig. S4).
The expression of IMPG1 & IMPG2 was conserved across the
three species examined (Fig. S5). IMPG1 and IMPG2 were strongly
expressed around the OS of the photoreceptors in the adult human
and monkey retina (Fig. S5), however expression around both inner
and outer segments was observed in the mouse retina (Fig. S5). In
adult human retina, IMPG1 was expressed in the rod photoreceptor
OS as shown by co-expression with the rod marker Rhodopsin
(Fig. S5). We were unable to perform co-immunostaining of IMPG1
with the cone markers (OPN1LW/MW) because the antibodies
were raised in the same species, however the widespread expres-
sion of IMPG1 immunostaining in the OS indicates that these
may include cone photoreceptors too (Fig. S5). IMPG2 expression
did not co-localise with Rhodopsin or opsin staining, thus indicat-
ing that IMPG2 is expressed around but not in the OS themselves.3.2. ECM component expression in developing human retina
To get insights on the expression dynamics of ECM components
during human retinal development, we took advantage of a recent
RNA-seq study of retinal samples obtained from 4.6 to 18 post con-
ception weeks (PCW) performed by our group [47]. This study
defined three developmental windows comprising 4.6–7.2 PCW,
7.7–10 PCW and 12–18 PCW which were characterised by stage
specific gene expression patterns corresponding to the emergence
of optic cup/RPE/lens, retinal ganglion cells (RGCs), and
photoreceptors/interneurons/Muller cells respectively. This analy-
sis revealed two key patterns for ECM expression: high expression
in the early developmental stages followed by a significant down-
regulation towards 12–18 PCW (COL4A1, FN1 and VCAN) and low
expression in early developmental stages followed by a significantReverse Primer
(Sequence (50->30)
NCBI Reference Sequence
GGCATGGACTGTGGTCATGAG NM_001256799.2
GATGAGACCTCCGTTTTGGA NM_020061
AGCCATAGCGTTCACCTACA NM_002900.2
GATGGTCCCGTTACCGTCC NM_002903
CCTCGGGGATGTACCTGGAC NM_000539.3
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CD44) (Fig. S6). These expression trends may suggest stage specific
roles played by various ECM components during retinogenesis or
changes from a more widespread to defined expression patterns
during retinal development. To investigate this in more detail,
we used IHC on embryonic and foetal retinal specimens from 6
to 19 PCW of human development as detailed below.3.2.1. Distribution of basement membrane glycoproteins
Collagen IV and Fibronectin are two major components of the
basement membranes and have been shown to play an important
role in optic cup morphogenesis [20]. Collagen IV was expressed in
the choroid and BrM during the 6–19 PCW (Fig. 1A). This result was
further corroborated by adjacent expression of the RPE marker,
RPE65 (Fig. S7A). Collagen IV was also expressed in the hyaloid
artery and lens capsule during the 6 PCW suggesting that it might
play an important role in their development. Faint expression of
Collagen IV was also detected in the RPE, Outer Neuroblastic Zone
(ONZ), IPL and Inner Neuroblastic Zone (INZ) across all stages
(Fig. 1A). The expression pattern of Collagen IV was consistent with
the expression observed in adult human retina described in the
previous section.
Fibronectin was expressed in BrM during the 12–19 PCW
(Fig. 1B). In addition, expression was detected in the ILM in theFig. 1. Expression of Collagen IV (Col4A1; A) & Fibronectin (FN1; B) in the human em
showing antibody labelling with and without Hoechst (Hoe) during the 6–19 PCW. Scale
and ILM.17 PCW and in the Choroid in 14–19 PCW (Fig. 1B). The expression
pattern of Fibronectin in BrM and ILM at 17 PCW was consistent
with the expression observed in adult human retina. Double stain-
ing of Fibronectin and Collagen IV confirmed that both of these
ECM components were expressed in BrM, although in different
parts with Fibronectin localised more basally than Collagen IV
(Fig. S7B).3.2.2. Distribution of Brevican & Versican
The expression of Brevican was observed throughout the retina
(ONZ, IPL and INZ) across all developmental stages (Fig. 2A). Strong
expression of Brevican was detected around developing photore-
ceptors (Fig. S7C, inset) and in the emerging space between the
RPE and ONZ often referred as the IPM during the 12–19 PCW
(Fig. 2A). Brevican was also detected in the surface ectoderm at 6
PCW and in the neural retina at 6 and 8 PCW (Fig. 2A). Versican
was expressed throughout the retina and strongly expressed
around the developing photoreceptors and IPM during the 12–17
PCW (Fig. 2B). Co-expression studies indicated that Brevican and
Versicanwere both expressed in the developing IPM; however their
expression did not overlap entirely (Fig. S7C). Versican expression
did, however, overlap with the IPM marker RBP3 and was located
above Recoverin-positive labelled photoreceptors (Fig. S7D), thus
corresponding with the expression observed in adult human retina.bryonic and foetal eye. (A, B) Sagittal sections through the developing human eye
bars = 20 mm. Arrows indicate Col4A1 expression in BrM and FN1 expression in BrM
Fig. 2. Expression of Brevican (BCAN; A) & Versican (VCAN; B) in the human embryonic and foetal eye. (A, B) Sagittal sections through the developing human eye showing
antibody labelling with and without Hoechst (Hoe) during the 6–19 PCW. Scale bars = 20 mm. Arrows indicate BCAN & VCAN expressions in IPM.
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Similar to Versican, strong expression of IMPG1 was observed
around the developing photoreceptors and emerging IPM during
the 12–19 PCW (Fig. 3A). This was confirmed by the co-
expression of IMPG1 with Versican (Fig. S7E). IMPG1 expression
was also detected across the neural retina from the 6–19 PCW.
Co-expression of IMPG1 with CRYAA (a lens-specific marker) was
observed in the lens at 6 PCW suggesting that IMPG1 might be
important for lens development (Fig. S7E). IMPG2 expression was
not detected until the 17 PCW (Fig. 3B). Co-expression of IMPG2
with Recoverin in the ONZ was observed in 19 PCW suggesting that
IMPG2 is expressed by the developing photoreceptors (Fig. S7F).
Co-expression of IMPG2 with RBP3 was also found in the develop-
ing IPM, thus corroborating the expression observed in the adult
human retina (data not shown).3.2.4. Distribution of cluster of differentiation 44 (CD44) in human
developing retina
CD44 acts as a receptor for Hyaluronic Acid and other ECMs
such as Versican, Brevican and Aggrecan [48,49]. It interacts with
the GAGs of IMPG1 and may participate in retinal adhesion [50].
It was, therefore, important to investigate CD44 expression in the
developing human retina. CD44 was found to be expressed in the
ONZ and INZ during the later stages of human retinal development
studied including 16–19 PCW (Fig. 4A). No immunostaining of
CD44 was detected in retinal sections from the 6th until the 14thPCW (Fig. 4A). Strong expression of CD44 was also observed in
the developing IPM in 16–19 PCW as revealed by the co-
localisation with RBP3 (Fig. 4B).3.3. ECM expression during differentiation of hESC and hiPSC to
laminated retina
Retinal organoids were generated from hESCs (H9) and hiPSCs
(SB-Ad3) following a differentiation protocol which was previously
described [7], with a few modifications highlighted in the methods
section (Fig. S8). The development of retinal progenitors and their
maturation over time was assessed using a combination of specific
markers (Fig. 5). VSX2, a marker of retinal progenitor and bipolar
cells, was expressed in the apical region of retinal organoids on
days 35 and 90 of differentiation (Fig. 5A). Amacrine and RGCs
(detected by the expression of HuC/D) were located in the basal
layer (toward the centre of the retinal organoids) (Fig. 5A). CRX,
a post-mitotic photoreceptor marker, was expressed throughout
the retinal organoids with strong expression towards the apical
region of the organoid as the photoreceptors developed over time
(Fig. 5A). Strong Recoverin expression was observed at days 90 and
150 (Fig. 5A). At day 150, there was no overlap between VSX2 and
CRX expression (Fig. 5A). PAX6 and VSX2 co-immunostaining
showed that bright VSX2 and bright PAX6 expressing cells did
not overlap, indicating that high VSX2 and high PAX6 expression
in the putative inner nuclear layer of day 150 retinal organoids
Fig. 3. Expression of Interphotoreceptor Matrix Proteoglycan 1 (IMPG1; A) & Interphotoreceptor Matrix Proteoglycan 2 (IMPG2; B) in the human embryonic and foetal eye. (A,
B) Sagittal sections through the developing human eye showing antibody labelling with and without Hoechst (Hoe) during the 6–19 PCW. Scale bars = 20 mm. Arrows indicate
IMPG1 & IMPG2 expressions in IPM.
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horizontal cells respectively, corroborating data published by Vol-
kner et al. [51]. Nonetheless, within the retinal organoids, we could
find cells with low PAX6 and low VSX2 expression which most
likely mark the remaining proliferating retinal progenitor cells
(Fig. S9), also shown by Ki67 expression (Fig. S9A). At day 150,
other cell types including amacrine, horizontal, ganglion and Mul-
ler glial cells were observed through immunostaining with AP2a,
Prox1, Cralbp (Figure S9A) in addition to the expression of presy-
naptic marker (Syntaxin), vGlut1 (expressed in photoreceptor
and bipolar cell terminals) and photoreceptor connecting cilia mar-
ker, ARL13B. At day 150, we also observed expression of Rhodopsin
in cell bodies and IS/OS like segments (Fig. S9A) in a similar pattern
reported by Gonzalez-Cordero et al. recently [8]. The expression of
cone markers (Cone Arrestin and long/medium wavelength Opsin)
was assessed from day 150; however a typical expression pattern
in cell bodies and IS/OS like segments was only observed from
day 200 onwards (Fig. S9B).
Immunostaining with antibodies against the selected ECM
components indicated that Fibronectin was expressed throughout
the 3D retinal organoids during the entire period of differentiation
in both hESC- and hiPSC-derived retinal organoids (Figs. 5B-D
and S10A-C). The expression of Collagen IV was detected in the
basement membrane on the luminal side of retinal organoids
(Figs. 5B-D and S10A-C).Versican was expressed throughout the retinal organoids with
strong apical expression at all stages of differentiation. Further-
more, Versican co-localised with RBP3 in both hESC- and hiPSC-
derived retinae at day 150 of differentiation (Figs. 5D and S10C),
indicating expression in the emerging IPM, thus corroborating data
obtained with developing and adult human retinae. A similar anal-
ysis in the hESC- and hiPSC-derived retinal sections showed high-
est expression of Brevican in the apical layer consisting of
photoreceptors marked by the CRX expression at days 90 and
150 of differentiation (Figs. 5C-D and S10B-C).
The expression of IMPG1 in retinal organoids was first evident
on day 90, with strong apical expression suggesting that IMPG1
might have a significant role in the development and maturation
of photoreceptors in vitro (Fig. 5C and D). IMPG1 expression in
hiPSC-derived retinal sections was only observed from day 120,
suggesting potential differences between hESC and hiPSC in the
kinetics of differentiation and/or IMPG1 expression (Fig. S10C). In
contrast, IMPG2 was not detected at all stages of hESC and hiPSC
retinal differentiation tested, suggesting that it might be expressed
at later stages of the differentiation process. Similar to IMPG1,
CD44 expression started at day 90 in the retinal organoids with
broad expression throughout neural retinal tissue and a strong
punctate-like pattern in the apical layer where Recoverin staining
was strongly detected (Fig. S11A-C). Co-immunostaining showed
CD44 co-expression with IPM marker RBP3 (Fig. S11D). However,
Fig. 4. Expression of cluster of differentiation 44 (CD44) in the human embryonic and foetal eye. (A) Sagittal sections through the developing human eye showing antibody
labelling with and without Hoechst (Hoe) during the 6–19 PCW. (B) Tissue labelled with CD44 and RBP3 antibodies in 16 PCW. Scale bars = 20 mm. Arrows indicate CD44
expressions in IPM.
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and outer segment marker (WGA, data not shown). Collectively,
these data indicate that Versican, Brevican, IMPG1 and CD44 were
expressed in the IPM of both human developing retina and human
pluripotent stem cells derived retinal organoids.
3.4. IMPG1 & CD44 receptors mediated effect on photoreceptors and
IPM development
In order to investigate the role of IMPG1 and CD44 in photore-
ceptor differentiation, blocking antibodies to IMPG1 and CD44
were added to retinal organoid culture media at day 90 and 150
of the differentiation process. IMPG1 antibody blocks the extracel-
lular cell binding domain (SEA domain) of the receptor, while CD44
blocks the LINK domain on the cell membrane [49,52]. Treated
groups were compared to a control group. After 14 days of incuba-
tion of retinal organoids at day 90 of differentiation with IMPG1
and CD44 blocking antibody, thinning of the phase bright neuroep-
ithelium typically found at the periphery of retinal organoids, was
observed in the group treated with IMPG1 antibody only
(Fig. S12A). However, the same experiment performed at day
150, indicated thinning of the neuroepithelium in both CD44 and
IMPG1 treated groups after 14 days of incubation with blocking
antibodies (Figs. S13 and S14A). After 14 days in culture, the effects
of IMPG1 and CD44 receptor inhibition at day 90 and 150 of differ-
entiation were assessed using IHC and qRT-PCR with retinal mark-ers including Recoverin (photoreceptor marker), Rhodopsin (rod
marker), WGA (cone and rod inner and outer segment marker
respectively), ARL13B (marker for connecting cilia) and RBP3
(IPM marker) to determine any effect on photoreceptors and/or
IPM development (Figs. 6 and S12–S15). No cone markers for
immunostaining analysis were included due to their emergence
from day 200 onwards.
The expression of RCVRN (Recoverin; Fig. S12B) and the number
of Recoverin positive cells (Fig. S15B) were significantly reduced
upon blocking of IMPG1 at day 90 of differentiation. The expression
of photoreceptor connecting cilia, ARL13B was also significantly
reduced upon blocking of IMPG1 function (Figure S15B), however
no changes in RBP3 expression were observed (Figs. S12B and
S15B), suggesting that IMPG1 plays a role in the development
and emergence of photoreceptors, but not IPM formation at this
developmental time point. Blocking of CD44 had no impact on
the gene or protein expression of photoreceptor, connecting cilia
or IPM markers at this time point (Figs. S12B, C and S15C). There
were no significant changes in Caspase 3 immunostaining for con-
trol, IMPG1 and CD44 blocked groups as assessed by IHC and quan-
tification at either day 90 or day 150 (data not shown). Blocking of
IMPG1 action at day 150 led to a significant reduction in the
expression of Recoverin and the number of Recoverin positive cells
within the retinal organoids (Figs. 6B and S14B, C). The expression
of the cone marker (OPN1LW/OPN1MW) was downregulated only
in the IMPG1 blocked group (Fig. S14B), although we could not
Fig. 5. Expression of selected ECM components during the differentiation of hESC to laminated retina. (A) H9-derived retinal organoid sections showing the development of
retinal progenitors and their maturation over time using retinal markers: VSX2, HuC/D, CRX and Recoverin. (B-D) H9-derived retinal organoid sections showing Fibronectin,
Collagen IV, Versican, Brevican, IMPG1 and IMPG2 antibody labelling with and without Hoechst on day 35 (B), day 90 and (C), day 150 (D). Scale bars = 20 lm.
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emergence (from day 200) of this cell type. The expression of Rho-
dopsin (RHO) and the number of Rhodopsin immunopositive cellswere reduced upon IMPG1 and CD44 blocking. In addition, the typ-
ical pattern of Rhodopsin immunostaining was lost in CD44 and
IMGP1 blocked groups (Fig. 6B, C), instead a punctate pattern at
Fig. 6. Blocking of IMPG1 & CD44 action affected the development of photoreceptors and interphotoreceptor matrix. Sections of retinal organoid derived from H9s showing
antibody labelling with and without Hoechst (Hoe) at day 164 in three different treatment groups: cultures treated with a non-specific IgG antibody (control, A), cultures
blocked with an IMPG1 antibody (B) and cultures blocked with a CD44 antibody (C). Antibody labelling was performed with Recoverin, Rhodopsin, ARL13B and RBP3. Small
insets show higher magnification images of organoid sections double labelled with Recoverin and WGA. Scale bars = 20 lm.
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with the cone and rod inner/outer segment marker WGA showed
a significant reduction in the IMPG1 and less so in the CD44
blocked group, suggesting that blocking the function of these two
ECM components interferes with the development of photorecep-
tor inner/outer segments at different extent (Fig. 6B, C). Further-
more, the expression of photoreceptor connecting cilia (ARL13B)
and IPM (RBP3) markers was significantly reduced in the IMPG1
treated group (Fig. 6B), indicating an important role for this protein
in cilia and IPM formation. ARL13B and RBP3 immunostaining
were also reduced in the CD44 blocked group, but less so when
compared to the IMPG1 treated group. Collectively, these data sug-
gest that IMPG1 and CD44 play an important role in the develop-
ment of photoreceptors, their inner and outer segments,
connecting cilia and IPM, with IMPG1 having an earlier and more
significant impact.4. Discussion
In this study the expression of key ECM components in adult
mouse and monkey retinae, developing and adult human retinae
and retinal organoids derived from hESC and hiPSC was investi-
gated (for summary of ECM expression, please see Figs. 7 and 8).
The results of this study demonstrate that different ECM compo-
nents have distinct distribution patterns throughout the adult
retina of different species [21]. Collagen IV was expressed in
BrM, while Fibronectin was expressed in BrM and ILM, consistent
with the expression previously observed in adult rat [53]. The cur-
rent study also indicated that the expression of Versican, Brevican,
IMPG1 and CD44 in the developing IPM was similar between
native human developing retina and pluripotent stem cell-
derived retinal organoids. IMPG2 was not expressed in retinal
organoids (up to day 150) included in this study. The same analysisof developing human retina indicated that expression of IMPG2
only starts from 17 PCW. It may therefore be possible, that IMPG2
is expressed in later stages of retinal organoid formation (after day
150); however, this remains to be investigated further. The block-
ing experiments indicated that inhibition of CD44 and IMPG1 had a
cell-type specific impact on the development of photoreceptors,
their inner and outer segments and IPM.
The expression data obtained from this study are largely
immunocytochemical and as such validation of antibody speci-
ficity is an important consideration. To address this, we employed
widely used controls for immunocytochemistry including: (i)
omission of primary antibodies; (ii) replacement of primary anti-
bodies with isotype controls; (iii) usage of antibodies that have
been widely published and validated in other studies. For example,
the IMPG2 antibody used in our study was validated through incu-
bation with pre-immune serum and shown to be expressed in the
IPM of human retina by Acharya et al. [54]. In addition, the Colla-
gen IV antibody used in our study showed a similar expression in
BrM of pig retina [55] and the size of CD44 protein detected with
the same antibody as us was confirmed by western immunoblot-
ting by Enkhjargal et al. [56]. For the rest of antibodies (BCAN,
VCAN, FN and IMPG1) where we felt that not enough literature evi-
dence was found, we performed RNAi studies which showed in all
cases a corresponding decrease in gene and protein expression by
qRT-PCR and immunocytochemistry (data not shown).
Since the seminal discovery of Eiraku and Sasai in 2011 on gen-
eration of 3D retinal organoids frommouse ESC, multiple protocols
have been developed and optimised for both human and mouse
pluripotent stem cells [57]. The initial stages of differentiation pro-
tocols that encompass formation of neural progenitors vary
between different published methods and include manipulation
of IGF-1 and Wnt and TGFb/activin signalling pathway [7,57]. The
second and longer stages of differentiation protocols that encom-
passes the formation of retinal progenitors, photoreceptor precur-
Fig. 7. Illustrated diagram showing a summary of ECM expression in human developing retina and adult human, monkey and mouse retinae.
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more similar to each other and in most cases include addition of
Fetal Calf Serum, Taurine and Retinoic Acid. Our differentiation
method was based on our previous publication which highlighted
enhanced formation of eye and optic cup like structures from hESC
by the addition of IGF-1 [7]. To obtain laminated retinal organoids
with high efficiency from both hESC and hiPSC, we have optimised
this protocol through the addition of Fetal Calf Serum, Retinoic
Acid, Taurine and Tri-iodothyronine (T3) from day 18 of differenti-
ation. Our data (Dorgau and Felemban, under preparation) indicate
that this optimised differentiation protocol results in formation of
laminated retinal organoids which contain all key retinal cell types,
form synaptic connections and respond to light. In view of these
results, this differentiation protocol was used for the ECM studies
described herein.
The IPM is a highly organised structure that surrounds the pho-
toreceptor cells and lies between the photoreceptors and the RPE
[18]. It has several prominent functions including regulating reti-
noid transport, maintenance of the photoreceptor-specific
microenvironment, cellular interactions, and retinal adhesion to
the RPE [18]. A major component of the IPM, is Hyaluronic Acid,
a large non-sulfated linear polysaccharide of (1-b-4) D-glucuronicacid and (1-b-3) N-acetyl-D-glucosamine [18]. Hyaluronic Acid
can bind to a number of proteins in the IPM such as hyalectins,
IMPG1 and IMPG2, forming a scaffold that fills the IPM
[3,18,24,58]. Preceding any experimental work to mimic the speci-
fic IPM environment, it is essential to understand the composition
of the IPM during human retinal organogenesis. Expression studies
were performed to map the differential distribution of proteogly-
can core proteins and their associated GAGs chain in sections of
developing human retina and retinal organoids obtained from
pluripotent stem cells. Versican was previously reported in the
IPM in adult chick [59]. The data obtained in the current study cor-
roborate this published report and also demonstrate Versican
expression in the IPM of adult human, mouse and monkey retina.
In the developing human retina and organoids generated from
pluripotent stem cells, Versican expression surrounded the devel-
oping photoreceptors between the RPE and ONZ, an area which
likely develops into the future IPM. The localisation of Versican
in the IPM was confirmed by co-expression with interphotorecep-
tor retinoid binding protein (IRBP/ RBP3), the most abundant pro-
tein in the IPM [60].
IMPG1 and IMPG2 are two specific ECM components that are
secreted by the photoreceptors into the IPM [34,54]. The results
Fig. 8. Illustrated diagram showing a summary of selected ECM expression during the differentiation of hESCs and hiPSCs to retinal organoids.
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IPM in human developing tissue, with IMPG1 detected earlier
and IMPG2 expressed at later stages of development, which may
suggest a role for IMPG1 in early photoreceptor development and
IMPG2 in photoreceptor maturation. This was corroborated by
function blocking experiments which indicated that IMPG1 plays
an important role in the development of photoreceptors as well
as formation of their inner/outer segments, connecting cilia and
IPM. Furthermore these data support the clinical phenotype of
Vitelliform Macular Dystrophy caused by IMPG1 mutations and is
characterised by impaired metabolism of photoreceptors in the
macula region due to the loss of IPM [36].
Several studies have demonstrated that CD44 is a multi-
domain protein that spans the plasma membrane of the cell
and acts as a receptor for Hyaluronic Acid and other ECMs such
as Versican, Brevican and Aggrecan [48,49]. CD44 can also inter-
act with the GAGs of IMPG1 and may participate in retinal adhe-
sion [50]. The results obtained in this study indicated that CD44
was expressed in the IPM from the 16 PCW of human develop-
ment. In retinal organoids, strong expression of CD44 was
observed in the apical layer where the IPM develops, suggesting
that CD44 may play an important role in the development of
the photoreceptors. Blocking of the CD44 receptor resulted in a
reduction in the number of rod photoreceptors within the retinal
organoids as well as the expression of connecting cilia marker
(ARL13B) and IPM marker (RBP3). Collectively these data suggest
that CD44 may play an important role in the development of pho-
toreceptors, in addition to being involved in formation of pho-
toreceptor connecting cilia and IPM.5. Conclusion
In summary, this study highlights a well conserved expression
for Versican, Brevican, IMPG1 and CD44 in the IPM of developing
human retina and retinal organoids. Furthermore, the study high-
lights an essential role for IMPG1 and CD44 in the development
of photoreceptors, their inner and outer segments, connecting cilia
and IPM, with IMPG1 having an earlier and more significant
impact. Future work will endeavour to investigate whether manip-
ulation of the ECM can accelerate and enhance retinal development
in vitro so that effective retinal cell therapy may be realised.
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